Published in Tumori on January 04, 1968
Discovery of new anticancer agents from higher plants. Front Biosci (Schol Ed) (2012) 0.92
(2S,3R,4S,4aR)-2,3,4,7-Tetra-hydroxy-3,4,4a,5-tetra-hydro-[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one hemihydrate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75
A rapid gas chromatographic method for the determination of thiamphenicol in body fluids and tissues. J Chromatogr (1973) 1.47
Drug/polymer matrix swelling and dissolution. Pharm Res (1988) 1.40
Narciclasine: an antimitotic substance from Narcissus bulbs. Nature (1967) 1.21
In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Control Release (2001) 1.08
Physical properties of parabens and their mixtures: solubility in water, thermal behavior, and crystal structures. J Pharm Sci (1999) 1.06
Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis Suppl (1980) 1.01
Polymorphism of bovine MHC class I genes. Joint report of the Fifth International Bovine Lymphocyte Antigen (BoLA) Workshop, Interlaken, Switzerland, 1 August 1992. Eur J Immunogenet (1994) 0.98
Dissecting aneurysm of the gastroduodenal artery: anatomic basis for the clinical syndrome of abdominal apoplexy. Ann Surg (1969) 0.97
Optimal conditions for ornithine carbamyl transferase determination. A simple micromethod without deproteinization. Clin Chim Acta (1973) 0.93
Lecithin organogel as matrix for transdermal transport of drugs. J Pharm Sci (1992) 0.89
Serum tissue polypeptide antigen in chronic pancreatic disease. Does hepatic damage have any influence? Ric Clin Lab (1985) 0.88
[Activity of narciclasine on mitosis of cells of the ascites sarcoma 180]. Tumori (1968) 0.88
Epidermal growth factor in the topical treatment of traumatic corneal ulcers. Ophthalmologica (1993) 0.87
Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances. Eur J Pharm Sci (2004) 0.87
Pharmacokinetics of oral acetylcysteine: absorption, binding and metabolism in patients with respiratory disorders. Clin Pharmacokinet (1978) 0.85
Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide. Eur J Pharm Sci (2001) 0.85
Pepsinogen Group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients. Clin Biochem (1983) 0.85
Esophageal-pericardial fistula presenting as pericarditis. Am Heart J (1983) 0.84
Thiamphenicol excretion in subjects with renal insufficiency. Int Z Klin Pharmakol Ther Toxikol (1970) 0.84
Elimination of chloramphenicol and thiamphenicol in subjects with cirrhosis of the liver. Int J Clin Pharmacol (1972) 0.84
Rotary tangential spray technique for aqueous film coating of indobufen pellets. Drug Dev Ind Pharm (1998) 0.83
Casein haplotype structure in five Italian goat breeds. J Dairy Sci (2005) 0.83
Programmable biodegradable implants. J Control Release (2001) 0.83
Improved direct specific determination of serum iron and total iron-binding capacity. Clin Chem (1980) 0.82
Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices. Biomaterials (2001) 0.82
Cross-linked sodium carboxymethylcellulose as a carrier for dissolution rate improvement of drugs. Boll Chim Farm (1990) 0.82
Ultramicrodetermination of plasma urea by reaction with diacetylmonoxime--antipyrine without deproteinization. Clin Chem (1971) 0.82
Catalytic acceleration of the urea-diacetylmonoxime-phenazone reaction and its application to automatic analysis. Clin Chim Acta (1965) 0.82
Effective surface area and activity of antacid preparations. Farmaco Prat (1985) 0.82
An improved proceure for blood glucose determination with o-toluidine. Clin Chim Acta (1969) 0.81
Thiamphenicol excretion in subjects with renal insufficiency. Int Z Klin Pharmakol Ther Toxikol (1970) 0.80
Swelling-activated drug delivery systems. Biomaterials (1988) 0.80
A new look at the measurement and interpretation of enzyme assays. Ann Clin Biochem (1976) 0.80
Monolithic triglyceride matrices: a controlled-release system for proteins. Pharm Dev Technol (2003) 0.79
Development of a single nucleotide polymorphism genotyping microarray platform for the identification of bovine milk protein genetic polymorphisms. J Dairy Sci (2007) 0.79
Successful treatment of acute allograft failure using pneumatic biventricular assistance. J Heart Lung Transplant (1991) 0.79
Thiamphenicol elimination in renal insufficiency. Postgrad Med J (1974) 0.79
Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneimittelforschung (1992) 0.78
Short communication: Carora cattle show high variability in alpha(s1)-casein. J Dairy Sci (2008) 0.78
Accelerated micro and ultramicro procedure for ornithine carbamyl-transferase (OCT) determination. Clin Chim Acta (1967) 0.78
Hyaluronidase-injectable microparticles intended for the treatment of extravasation. J Microencapsul (1998) 0.77
Trypsin plasma-urine transfer--a preliminary study. Clin Chim Acta (1981) 0.77
Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: an investigation into the mechanisms governing drug release. J Pharm Sci (2007) 0.77
[Coronary risk factors and ischemic heart disease in bus drivers and conductors]. Minerva Cardioangiol (1975) 0.77
Multicenter open trial of cefotetan and cefoxitin in elective biliary surgery. Am J Surg (1988) 0.76
Characterization and genetic study of the ovine alphaS2-casein (CSN1S2) allele B. Protein J (2009) 0.76
Epidermal growth factor in the topical treatment of herpetic corneal ulcers. Ophthalmologica (1994) 0.76
Chemical and pharmacological investigations of constituents of Eleutherine bulbosa (Miller) Urb. (Iridaceae). J Pharm Sci (1975) 0.76
Dopamine, dopaminergic drugs and ocular hypertension. Int Ophthalmol (1992) 0.76
In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic technology). Boll Chim Farm (1999) 0.76
Proceedings: Newer developments in chloramphenicol metabolism. Br J Pharmacol (1974) 0.75
Anti-catalase activity of phenylenediamines in vitro and in vivo. Enzymologia (1966) 0.75
Absorption of sodium diclofenac after ocular administration in rabbit. Arzneimittelforschung (1998) 0.75
Identification of thiamphenicol excretion products in rat urine using gas-chromatography--mass-spectrometry. Postgrad Med J (1974) 0.75
[Pre-analysis variability: the effect of evaporation on the error of measurement, with special reference to sodium and potassium]. Quad Sclavo Diagn (1984) 0.75
[Classification of hyperlipoproteinemias in hospitalized patients]. G Clin Med (1972) 0.75
Increase of chloramphenicol glucuronidation in rats treated with phenobarbital. Biochem Pharmacol (1974) 0.75
Polymorphism of NCX4016, an NO-releasing derivative of acetylsalicylic acid. J Pharm Sci (2004) 0.75
[Use of LKB 8600 analyzer for semiautomatic measuring of enzyme kinetics in clinical chemistry]. Quad Sclavo Diagn (1972) 0.75
A sensitive method for serum ornithine carbamyltransferase determination. Clin Chim Acta (1966) 0.75
[Behavior of blood sugar, lactic acid, pyruvic acid and NEFA in premature infants with and without feeding in the first 24 hours of life]. Minerva Pediatr (1976) 0.75
[Elimination of chloramphenicol and thiamphenicol in patients with liver cirrhosis]. Boll Chim Farm (1972) 0.75
[Optimization and standardization of measurements of enzyme activity]. Ric Clin Lab (1980) 0.75
Active packaging for topical cosmetic/drug products: a hot-melt extruded preservative delivery device. Eur J Pharm Biopharm (2010) 0.75
A route to the total synthesis of iso-LTB4 system. Farmaco Sci (1985) 0.75
[Biochemical and electrocardiographic evaluation of acetylcysteine in intravenous administration]. Clin Ter (1971) 0.75
[Electrophoretic and enzymologic aspects of chronic hepatitis]. Quad Sclavo Diagn (1972) 0.75
[Anticatalase action in vitro and in vivo of cysteine, tyrosine and some related compounds in relation to the anticatalase activity of tumors]. Tumori (1966) 0.75
[Determination of some organ-specific enzymes: recent progress in methodology and diagnostic applications]. Ann Ist Super Sanita (1971) 0.75
[Description of therapeutic systems using transmucosal absorption]. Boll Chim Farm (1984) 0.75
[Significance of serum ornithine carbamoyl-transferase (OCT) in the toxicological study of new drugs]. Boll Chim Farm (1972) 0.75
Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration. J Chromatogr (1989) 0.75
[Bioadhesives: rationale, state of the art and therapeutic potential]. Boll Chim Farm (1995) 0.75
Simulation of the disintegration process of pharmaceutical tablets. Pharm Acta Helv (1988) 0.75
Ocular pharmacokinetics and pharmacodynamics in rabbits of ibopamine, a new mydriatic agent. Exp Eye Res (1993) 0.75
Aluminum-magnesium antacids and the bioavailability of ketoscilium in man. Arzneimittelforschung (1979) 0.75
[Proceedings: Significance of free glycerol level in the enzymatic determination of serum triglycerides]. Quad Sclavo Diagn (1973) 0.75
Optimisation and scale-up of a highly-loaded 5-ASA multi-particulate dosage form using a factorial approach. Eur J Pharm Sci (2011) 0.75
A physiochemical approach to the investigation of the stability of trimethoprim-sulfamethoxazole (co-trimoxazole) mixtures for injectables. J Pharm Sci (1995) 0.75
Crystal forms of piroxicam pivalate: preparation and characterization of two polymorphs. J Pharm Sci (1998) 0.75
Structural characterization of two polymorphic forms of piroxicam pivalate. J Pharm Sci (1998) 0.75
[Consideration on the King-Armstrong method and on the kinetic method for the measurement of the alkaline phosphatase activity in serum (author's transl)]. Quad Sclavo Diagn (1976) 0.75
Monolithic glyceryl trimyristate matrices for parenteral drug release applications. Eur J Pharm Biopharm (2003) 0.75
Extrusion-spheronisation of highly loaded 5-ASA multiparticulate dosage forms. Int J Pharm (2010) 0.75
[Alpha-lipoproteins and viral hepatitis (author's transl)]. Quad Sclavo Diagn (1978) 0.75
[The use of cimetidine in renal insufficiency under hemodialytic treatment]. Minerva Nefrol (1981) 0.75
Ocular pharmacokinetics of thiamphenicol in rabbits. Arzneimittelforschung (1992) 0.75
Distribution of khellin in excised human skin following iontophoresis and passive dermal transport. J Control Release (1999) 0.75
Photometric evaluation of dye diffusion in the skin. J Pharm Pharmacol (1970) 0.75
[Glucuroconjugation in vitro of chloramphenicol in normal rats and in rats pre-treated with phenobarbital]. Boll Chim Farm (1974) 0.75
[Excretion of thiamphenicol in subjects with renal insufficiency]. Boll Chim Farm (1970) 0.75
Senile cataractic lenses do not accumulate galactitol in either lactose tolerant or intolerant subjects. Clin Chim Acta (1993) 0.75
Effect of partial hepatectomy and renal impairment of thiamphenicol metabolism in rats. Pharmacol Res Commun (1977) 0.75
Swelling-restricted minimatrices for controlled release of drugs. Preliminary in-vivo studies. Boll Chim Farm (1989) 0.75
A combat casualty course for increasing the operational readiness of reserve component health care professionals. Mil Med (1985) 0.75
[Plasma lipids in normal subjects, and in patients with coronary disease and peripheral arteriopathy]. Minerva Med (1973) 0.75
Polymorphism of rac-5,6-diisobutyryloxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene hydrochloride (CHF 1035). I. Thermal, spectroscopic, and X-ray diffraction properties. J Pharm Sci (2001) 0.75